Big Pharma Split Balance Sheet Health
Financial Health criteria checks 3/6
Big Pharma Split has a total shareholder equity of CA$15.9M and total debt of CA$10.3M, which brings its debt-to-equity ratio to 65%. Its total assets and total liabilities are CA$26.5M and CA$10.7M respectively.
Key information
65.0%
Debt to equity ratio
CA$10.30m
Debt
| Interest coverage ratio | n/a |
| Cash | CA$204.19k |
| Equity | CA$15.85m |
| Total liabilities | CA$10.68m |
| Total assets | CA$26.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PRM.PRA's short term assets (CA$999.5K) do not cover its short term liabilities (CA$10.7M).
Long Term Liabilities: PRM.PRA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PRM.PRA's net debt to equity ratio (63.7%) is considered high.
Reducing Debt: PRM.PRA's debt to equity ratio has reduced from 71.2% to 65% over the past 5 years.
Debt Coverage: PRM.PRA's debt is well covered by operating cash flow (115.2%).
Interest Coverage: Insufficient data to determine if PRM.PRA's interest payments on its debt are well covered by EBIT.